Oncology Cancer Drugs Market Size is projected to reach USD 288 Billion by 2030, growing at a CAGR of 7.7%: Straits Research
The global oncology cancer drugs market size was valued at USD 148,050.6 million in 2021. It is expected to reach USD 288,636.6 million by 2030, growing at a CAGR of 7.7% during the forecast period (2022–2030). North America is the most dominant and is estimated to grow at a CAGR of 6.7% during the forecast period
New York, United States, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Cancer develops when the body's common control mechanism malfunctions and cannot stop the proliferation of abnormal cells. In this case, old cells don't die but continue to divide uncontrollably, resulting in new abnormal cells. Cancer patients may be treated with chemotherapy, hormonal therapy, immunotherapy, targeted therapy, and targeted therapy. Biopharmaceuticals made from monoclonal antibodies (mAbs), also known as biological drugs, have emerged as a promising treatment for various cancer types. The rising incidence of different cancer conditions, the increasing popularity of advanced therapies (such as biological and targeted drug therapies), and the rise in the global population of older adults are driving the growth of the worldwide oncology/cancer drug market. Cancer awareness and early cancer screenings are expected to drive the market's development and the availability of cancer drugs.
Get a Free Sample Copy of This Report https://straitsresearch.com/report/oncology-cancer-drugs-market/request-sample
Growing Cancer Diagnoses and Global Ageing Drives the Global Market
Patients with lung, bone, and other cancers often take painkillers, including morphine, fentanyl, acetaminophen, and nonsteroidal anti-inflammatory drugs (NSAIDs). There has been a significant rise in the amount of money spent on cancer-fighting medications due to an increase in the number of people diagnosed with the disease. Because of this, an increase in cancer cases is expected to fuel the market's expansion.
The world's population is growing at a rate never before, especially compared to younger age groups. It is predicted that by 2060, "the number of Americans aged 65 and older will increase more than double over 95 million, and it will rise to approximately 23 percent from 16 percent," published by the Population Reference Bureau. However, the American Cancer Society Journal estimates that approximately 140,690 people in the United States are diagnosed with cancer each year and that 103,250 people die of cancer each year. Second, only cardiovascular disease, cancer, is the most common cause of death worldwide, according to the WHO. As a result, the elderly population is expected to increase the demand for cancer management drugs, which will, in turn, boost the market's growth.
Untapped Growth in Emerging Economies Creates Tremendous Opportunities
The United States and Europe are the largest markets for cancer medications. Asia and the Pacific are home to 60% of the world's population, so there is much room to grow the market here. A contributing factor to the rise in these diseases across Asia is the high prevalence of tobacco use, a known carcinogen associated with oral and laryngeal cancers and other conditions. Asia-Pacific, Latin America, and the Caribbean are expected to grow significantly shortly. Due to an increase in healthcare infrastructure, affordability, and awareness about the importance of early cancer diagnosis, including oral cancer. In addition, the healthcare industry is increasing in developing countries. This is due to rising demand for high-quality healthcare services, significant healthcare infrastructure investments by governments worldwide, and increased medical tourism to developing countries. In light of these factors, we can expect that the market for cancer drugs will have a lot of room for growth.
Report Scope
Report Metric | Details |
Market Size | USD 288 Billion by 2030 |
CAGR | 7.7% (2020-2030) |
Historical Data | 2019-2020 |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Drug Class Type, Indication and Region |
Geographies Covered | North America, Europe, Asia-Pacific, LAME and Rest of the World |
Key Companies Profiled/Vendors | AbbVie Inc., Amgen, Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Hoffmann-La Roche Ltd., Johnson & Johnson (Janssen Global Services, LLC), Merck & Co., Inc., Novartis AG, Pfizer Inc. |
Key Market Opportunities | High Growth Potential in Emerging Economies to Spur Market Opportunities |
Key Market Drivers | Increasing Number of People Diagnosed with Cancer to Foster Market Growth |
Buy Now Full Report https://straitsresearch.com/buy-now/oncology-cancer-drugs-market
Regional Analysis
North America is the most dominant and is estimated to grow at a CAGR of 6.7% during the forecast period. The availability of top-notch treatment options, a rise in product approvals, and increased public awareness of early cancer detection are just a few factors that will contribute to the market's continued expansion. This is expected to occur shortly. In addition, rapid advancements in tumor biology, genetics, and immunology have led to the creation of several new cancer drugs in this part of the world. North America is anticipated to provide market players in the future with new opportunities. For instance, different companies such as Abbie, Amgen Inc., Johnson & Johnson, and Pfizer Inc. are all examples of companies that offer pipeline products. As a result, the presence of several drugs already in the pipeline, including ideal medications currently in the late stage of development, is anticipated to provide lucrative opportunities for market expansion.
Key Highlights
The global oncology cancer drugs market size was valued at USD 148,050.6 million in 2021. It is expected to reach USD 288,636.6 million by 2030, growing at a CAGR of 7.7% during the forecast period (2022–2030).
Based on the drug class type, the global oncology cancer drugs market has been categorized into chemotherapy, targeted therapy, immunotherapy (biologic therapy), and hormonal therapy. The targeted therapy segment is the highest contributor to the market and is estimated to grow at a CAGR of 8.2% during the forecast period.
Based on the indication, the global oncology cancer drug market has been categorized into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer, and bladder cancer. The breast cancer segment is the highest contributor to the market and is estimated to grow at a CAGR of 8.3% during the forecast period.
North America is the most dominant and is estimated to grow at a CAGR of 6.7% during the forecast period.
Get a Free Sample Copy of This Report https://straitsresearch.com/report/oncology-cancer-drugs-market/request-sample
Competitive Analysis
AbbVie Inc.
Amgen
Astellas Pharma Inc.
AstraZeneca PLC
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Johnson & Johnson (Janssen Global Services, LLC)
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Global Oncology Cancer Drugs Market: Segmentation
By Drug Class Type
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
By Indication
Lung Cancer
Stomach Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Liver Cancer
Esophagus Cancer
Cervical Cancer
Kidney Cancer
Bladder Cancer
By Region
North America
Europe
Asia-Pacific
LAMEA
TABLE OF CONTENT
Introduction
Market Definition
Market Scope
Research Methodology
Primary Research
Research Methodology
Assumptions & Exclusions
Secondary Data Sources
Market Overview
Report Segmentation & Scope
Value Chain Analysis: Oncology Cancer Drugs Market
Key Market Trends
Drivers
Restraints
Opportunities
Porter’s Five Forces Analysis
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of Substitution
Threat of New Entrants
Competitive Rivalry
Market Share Analysis
Type Overview
Introduction
Market Size & Forecast
Chemotherapy
Market Size & Forecast
Targeted Therapy
Market Size & Forecast
Indication Overview
Introduction
Market Size & Forecast
Lung Cancer
Market Size & Forecast
Stomach Cancer
Market Size & Forecast
Regional Overview
Introduction
Market Size & Forecast
America
North America
U.S.
By Type
By Indication
Canada
By Type
By Indication
Mexico
By Type
By Indication
Latin America
By Type
By Indication
Europe
Market Size & Forecast
Germany
By Type
By Indication
France
By Type
By Indication
U.K.
By Type
By Indication
Italy
By Type
By Indication
Spain
By Type
By Indication
Rest of Europe
By Type
By Indication
Asia Pacific
Market Size & Forecast
Japan
By Type
By Indication
China
By Type
By Indication
Australia
By Type
By Indication
India
By Type
By Indication
South Korea
By Type
By Indication
Rest of Asia-Pacific
By Type
By Indication
Middle East & Africa
Market Size & Forecast
Saudi Arabia
By Type
By Indication
South Africa
By Type
By Indication
Kuwait
By Type
By Indication
Rest of Middle East & Africa
By Type
By Indication
Company Profile
AbbVie Inc
Company Overview
Financial Performance
Recent Developments
Product Portfolio
Amgen
Company Overview
Financial Performance
Recent Developments
Product Portfolio
Astellas Pharma Inc
Company Overview
Financial Performance
Recent Developments
Product Portfolio
Conclusion & Recommendation
Acronyms & Abbreviations
Tables of Content and figures https://straitsresearch.com/report/oncology-cancer-drugs-market/toc
News Media
Precision Cancer Therapy has been Instrumental in the Growing Adoption of PGX Technologies
Here is All You Need to Know About Cancer
Oncology Market Potential Revenue and Future Growth with Healthy CAGR by 2029
Advancements in Ovarian Cancer Diagnostics to Escalate the Market Growth in Future
Have a Look at the Related Research Report
Clinical Oncology Next Generation Sequencing Market: Information by Workflow (Pre-Sequencing, Sequencing), Technology (Whole Genome Sequencing), and Region — Forecast till 2030
Oncology Precision Medicine Market: Information by Product type (Diagnostics, Therapeutics), Applications (Breast cancer, Lung cancer), and Region — Forecast till 2030
Veterinary Oncology Market: Information by Therapy (Surgery, Radiology, Chemotherapy), Animal Type (Canine, Feline), Cancer Type (Lymphoma, Mammary), and Region—Forecast till 2029
Oncology Nutrition Market: Information by Cancer Type (Head, Blood, Pancreas, Breast, Neck, and Stomach and Gastrointestinal Cancer), and Region-Forecast till 2029
Oncology Information System Market: Information by Products and Services (Software, Professional Services), Application (Medical, Radiation, & Surgical Oncology), End User—Forecast Till 2026
About Straits Research Pvt. Ltd.
StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
For more information on your target market, please contact us below:
Phone: +1 646 480 7505 (the U.S.)
+91 8087085354 (APAC)
+44 208 068 9665 (the U.K.)
Email: sales@straitsresearch.com
Follow Us: LinkedIn | Facebook | Instagram | Twitter